Fortamet, Glucophage, Glumetza, Riomet, Riomet Er, Vipdomet (metformin) is a small molecule pharmaceutical. Metformin was first approved as Fortamet on 1995-03-03. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus. It is known to target solute carrier family 22 member 3, 5'-AMP-activated protein kinase subunit beta-1, solute carrier family 22 member 2, multidrug and toxin extrusion protein 1, multidrug and toxin extrusion protein 2, and cytochrome P450 3A4. Metformin hydrochloride's patents are valid until 2035-05-01 (FDA).
|Indication||type 2 diabetes mellitus|
|Drug Class||Hypoglycemics (phenformin type)|